1-13 of 13
Tao Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT152: A multicenter Phase II study of savolitinib in patients with MET-amplified gastroesophogeal junction adenocarcinomas or gastric cancer

Zhi Peng, Hua Wang, Baorui Liu, Huiting Xu, Zhenyang Liu, Tianshu Liu, Jun Zhang, Yuxian Bai, Ying Yuan, Tao Wu, Feng Ye, Qinghua Pan, Jufeng Wang, Enxiao Li, Diansheng Zhong, Yueyin Pan, Yanru Qin, Yan Yang, Yusheng Wang, Aiping Zhou, Yongshun Chen, Dianbao Zhang, Hongli Liu, Xiujuan Qu, Shubin Wang, Ning Liu, Jinsheng Wu, Wei Li, Kejun Nan, Hongming Pan, Jianming Xu, Chunmei Bai, Heling Liu, Jia Wei, Runzhi Chen, Rongrong Li, Wei Li, Jinghong Zhou, Hongyan Yin, Qian Xu, Songhua Fan, Yongxin Ren, Weiguo Su, Lin Shen
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT152.
https://doi.org/10.1158/1538-7445.AM2023-CT152
Published: 14 April 2023
View articletitled, Abstract CT152: A multicenter Phase II study of savolitinib in patients with MET-amplified gastroesophogeal junction adenocarcinomas or gastric cancer
Journal Articles

Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution—Reply

Tao Wu, Kaixuan Diao, Xue-Song Liu
Journal: Cancer Research
Cancer Res (2023) 83 (6): 973.
https://doi.org/10.1158/0008-5472.CAN-22-3218
Published: 15 March 2023
View articletitled, Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution—Reply
Open the PDF for Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution—Reply in another window
Includes: Supplementary data
Journal Articles

Abstract P1-13-02: The Aberrant Activity of Retrotransposon Elements Mediates the Chemo-tolerant Persister Cells Relapse in TNBC

Zijian Zhang, Yiyang Wang, Xinluo Luo, Xuwen Li, Xiaomei Zhan, Yumin Zheng, Jun Ding, Tao Wu
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P1-13-02.
https://doi.org/10.1158/1538-7445.SABCS22-P1-13-02
Published: 01 March 2023
View articletitled, Abstract P1-13-02: The Aberrant Activity of Retrotransposon Elements Mediates the Chemo-tolerant Persister Cells Relapse in TNBC
Journal Articles

Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution

Tao Wu, Guangshuai Wang, Xuan Wang, Shixiang Wang, Xiangyu Zhao, Chenxu Wu, Wei Ning, Ziyu Tao, Fuxiang Chen, Xue-Song Liu
Journal: Cancer Research
Cancer Res (2022) 82 (12): 2226–2238.
https://doi.org/10.1158/0008-5472.CAN-21-3717
Published: 15 June 2022
View articletitled, Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution
Open the PDF for Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution in another window
Includes: Supplementary data
Journal Articles

Abstract 929: Discovery of novel covalent KRASG12C inhibitors that display high potency and selectivity in vitro and in vivo

Liansheng Li, Matthew R. Janes, Jingchuan Zhang, Rasmus Hansen, Ulf Peters, Xin Guo, Yuching Chen, Anjali Babbar, Sarah J. Firdaus, Jun Feng, Jeffrey H. Chen, Shuangwei Li, Shisheng Li, Carol Thach, Yuan Liu, Ata Zarieh, Jeff M. Kucharski, Tao Wu, Ke Yu, Yi Wang, Yvonne Yao, Xiaohu Deng, Patrick P. Zarrinkar, Dashyant Dhanak, Matthew V. Lorenzi, Dana Hu-Lowe, Pingda Ren, Yi Liu
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 929.
https://doi.org/10.1158/1538-7445.AM2018-929
Published: 01 July 2018
View articletitled, Abstract 929: Discovery of novel covalent KRASG12C inhibitors that display high potency and selectivity in vitro and in vivo
Journal Articles

Abstract 3885: 11q13 amplification selects for sensitivity to the ERK inhibitor KO-947 in squamous cell carcinomas

Francis J. Burrows, Linda Kessler, Tao Wu, Xin Gao, Jeffrey Chen, Rasmus Hansen, Shuangwei Li, Carol Thach, Shisheng Li, Ke Yu, Jeff Kucharski, Ulf Peters, Jun Feng, Yi Wang, Yvonne Yao, Ata Zarieh, Matt Janes, Jingchuan Zhang, Liansheng Li, Dana Hu-Lowe, Pingda Ren, Yi Liu
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3885.
https://doi.org/10.1158/1538-7445.AM2018-3885
Published: 01 July 2018
View articletitled, Abstract 3885: 11q13 amplification selects for sensitivity to the ERK inhibitor KO-947 in squamous cell carcinomas
Journal Articles

Abstract 5168: KO-947, a potent ERK inhibitor with robust preclinical single agent activity in MAPK pathway dysregulated tumors

Francis Burrows, Linda Kessler, Jeffrey Chen, Xin Gao, Rasmus Hansen, Shuangwei Li, Carol Thach, Levan Darjania, Yvonne Yao, Yi Wang, Ata Zarieh, Ke Yu, Tao Wu, Jingchuan Zhang, Dana Hu-Lowe, Liansheng Li, Pingda Ren, Yi Liu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5168.
https://doi.org/10.1158/1538-7445.AM2017-5168
Published: 01 July 2017
View articletitled, Abstract 5168: KO-947, a potent ERK inhibitor with robust preclinical single agent activity in MAPK pathway dysregulated tumors
Journal Articles

Abstract 5077: A novel small molecule menin-MLL inhibitor for potential treatment of MLL-rearranged leukemias

Tao Wu, Linda Kessler, Shuangwei Li, Trupta Purohit, Shisheng Li, Hongzhi Miao, Brian Linhares, Rasmus Hansen, Jeff Kucharski, Yi Wang, Ke Yu, Katarzyna Kempinska, Tess Ely, Szymon Klossowski, Ata Zarieh, Ulf Peters, Jun Feng, Yvonne Yao, Yuan Liu, Bo Wen, Francis Burrows, Duxin Sun, Jingchuan Zhang, Levan Darjania, Dana Hu-Lowe, Patrick Zarrinkar, Liansheng Li, Tomasz Cierpicki, Jolanta Grembecka, Pingda Ren, Yi Liu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5077.
https://doi.org/10.1158/1538-7445.AM2017-5077
Published: 01 July 2017
View articletitled, Abstract 5077: A novel small molecule menin-MLL inhibitor for potential treatment of MLL-rearranged leukemias
Journal Articles

Abstract 4520: Biological coupling: Drug synergy, cross-resistance, and schedule effects in combination therapy

Andrew Chen, Christopher J. Zopf, Jing-Tao Wu, Wen Chyi Shyu, Arijit Chakravarty
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4520.
https://doi.org/10.1158/1538-7445.AM2015-4520
Published: 01 August 2015
View articletitled, Abstract 4520: Biological coupling: Drug synergy, cross-resistance, and schedule effects in combination therapy
Journal Articles

Abstract 4527: Dosing schedule effects on combination activity from first principles

Andrew Chen, Jing-Tao Wu, Wen Chyi Shyu, Arijit Chakravarty, Christopher J. Zopf
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4527.
https://doi.org/10.1158/1538-7445.AM2015-4527
Published: 01 August 2015
View articletitled, Abstract 4527: Dosing schedule effects on combination activity from first principles
Journal Articles

Abstract 3242: Xenograft dose-response from intra-mouse dose escalation

Andrew Chen, Christopher J. Zopf, Jing-Tao Wu, Wen Chyi Shyu, Arijit Chakravarty
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3242.
https://doi.org/10.1158/1538-7445.AM2015-3242
Published: 01 August 2015
View articletitled, Abstract 3242: Xenograft dose-response from intra-mouse dose escalation
Journal Articles

Abstract 3759: Xenograft rebound kinetics are consistent with the founder effect

Andrew Chen, Christopher J. Zopf, Jing-Tao Wu, Wen Chyi Shyu, Arijit Chakravarty
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3759.
https://doi.org/10.1158/1538-7445.AM2015-3759
Published: 01 August 2015
View articletitled, Abstract 3759: Xenograft rebound kinetics are consistent with the founder effect
Journal Articles

Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4

Zhongxing Liang, Tao Wu, Hong Lou, Xiwen Yu, Russell S. Taichman, Stephen K. Lau, Shuming Nie, Jay Umbreit, Hyunsuk Shim
Journal: Cancer Research
Cancer Res (2004) 64 (12): 4302–4308.
https://doi.org/10.1158/0008-5472.CAN-03-3958
Published: 17 June 2004
View articletitled, Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4
Open the PDF for Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4 in another window